The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
120 jobs Number of planned job creations
Announcement Date
20 February 2008
Employment effect (start)
1 July 2008
Foreseen end date
1 July 2011
Description
The Indian pharmaceutical company Aurobindo Pharma has announced it will invest 10 million euro in setting up a manufacturing plant in the Hal Far Industrial Estate, Malta, which will employ up to 120 people later in 2008. The Maltese site will concentrate on the manufacture of pharma-finished formulas and will supply services including laboratory testing, quality assurance and the validating of pharmaceutical products for EU customers and is expected to reach sales of 26 million euro by 2013. The move is designed to help Aurobindo expand its European markets share. The company’s vice president gave the reasons for the decision to set up in Malta as being due, among others, to the English-speaking workforce, reduced income tax regime and ease of investment. Aurobindo, which is one of the top five pharmaceutical companies in India, operates in over 100 countries, employs about 7,000 persons worldwide and had a turnover exceeding half a billion euros in 2007. Among others, it specializes in the production of anti-infectives, antiretrovirals and cardiovascular drugs.
Eurofound (2008), Aurobindo Pharma, Business expansion in Malta, factsheet number 66359, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/66359.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...